Breaking News Instant updates and real-time market news.

TRVN

Trevena

$6.03

0.11 (1.86%)

13:53
10/19/16
10/19
13:53
10/19/16
13:53

Meet Trevena: CEO Gowen expects new clinical trial data in Q1

In an exclusive interview with The Fly, Trevena's (TRVN) CEO Maxine Gowen discussed the company's primary drug candidate Oliceridine, or TRV130, and its ongoing Phase 3 studies: "We are still expecting to share the top line data from both [Oliceridine] APOLLO studies in the first quarter of 2017 as we have guided. Our goal for Oliceridine is a labeled indication for the management of moderate to severe acute pain. So that means any moderate to severe pain when an IV medicine is appropriate and that's regardless of what causes the pain. According to FDA, you can get a broad label like this or this can be supported by demonstrating efficacy in both the hard tissue and the soft tissue pain in the case study. So that's why our Phase 3 program includes bunionectomy, which is a hard tissue model of bone surgery, and an abdominoplasty trial, which is a soft tissue model. We use both of these models in the Phase 2 trials and from that we generated the very compelling data around Oliceridine's efficacy as well as safety and tolerability compared to morphine. So with those two [APOLLO] pivotal trials as well as the multi procedure ATHENA study, which is a trial we're doing, we believe that we'll have sufficient data to support that broad label indication without the need to do any further trials." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

  • 22

    Oct

  • 13

    Dec

TRVN Trevena
$6.03

0.11 (1.86%)

03/02/16
WBTH
03/02/16
INITIATION
Target $18
WBTH
Buy
Trevena initiated with a Buy at WallachBeth
WallachBeth analyst Caroline Palomeque started Trevena with a Buy rating and $18 price target. The company's lead candidate Oliceridine for post-operative acute pain may offer patients a treatment option with comparable analgesic efficacy, a faster onset of action and a more favorable safety profile than morphine, Palomeque tells investors in a research note.
03/02/16
03/02/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chemical Financial (CHFC) initiated with a Strong Buy at Raymond James by analyst David Long, who believes its pending accretive merger with Talmer Bancorp (TLMR) will provide the base for a more profitable company with strengthened growth prospects. 2. Infinity Pharmaceuticals (INFI) initiated with an Outperform at FBR Capital, with analyst Christopher James saying that duvelisib has the potential to be a first-in-class treatment for specific types of blood cancers. 3. Trevena (TRVN) initiated with a Buy at WallachBeth by analyst Caroline Palomeque, who said Oliceridine may offer patients a treatment option with comparable analgesic efficiency, a faster onset of action and a more favorable safety profile than morphine. 4. Aduro Biotech (ADRO) initiated with an Outperform at FBR Capital. 5. LKQ Corp. (LKQ) initiated with a Buy at Sterne Agee CRT. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/16
FBRC
03/29/16
INITIATION
Target $16
FBRC
Outperform
Trevena initiated with an Outperform at FBR Capital
FBR Capital analyst Christopher James started Trevena with an Outperform rating and $16 price target.
05/17/16
ROTH
05/17/16
NO CHANGE
Target $14.5
ROTH
Buy
Roth Capital remains a buyer of Trevena
Roth Capital analyst Michael Higgins reiterates a Buy rating and $14.50 price target on Trevena's shares. The analyst says the company announced that its TRV027 failed in Phase 2 and will be discontinuing the program. However, given the relative risk of development between its oliceridine and its TRV027, Higgins is not making any changes to his financial models. Trevena is "well-capitalized," with cash sufficient to fund operations for two years, the analyst tells investors in a research note, adding that he sees the company's shares as being at an "attractive entry point."

TODAY'S FREE FLY STORIES

NRZ

New Residential

$16.85

0.31 (1.87%)

13:46
04/26/17
04/26
13:46
04/26/17
13:46
Options
New Residential call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

PGH

Pengrowth Energy

$1.01

-0.0065 (-0.64%)

13:45
04/26/17
04/26
13:45
04/26/17
13:45
Upgrade
Pengrowth Energy rating change  »

Pengrowth Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

, ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Energy Transfer Partners holders approve Sunoco Logistics merger »

Sunoco Logistics Partners…

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

ETE

Energy Transfer Equity

$19.33

0.78 (4.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    May

XOM

Exxon Mobil

$81.98

0.25 (0.31%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Exxon Mobil raises dividend to 77c from 75c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ATVI

Activision Blizzard

$51.36

0.48 (0.94%)

13:39
04/26/17
04/26
13:39
04/26/17
13:39
Hot Stocks
Activision Blizzard unveils next 'Call of Duty,' says launching November 3 »

Activision Blizzard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

NTRA

Natera

$8.62

0.26 (3.11%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Hot Stocks
Natera, Cancer Research UK publish results from 100 patients in TRACERx study »

Natera and Cancer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

HCLP

Hi-Crush Partners

$15.05

-0.05 (-0.33%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Options
Hi Crush Partners calls are active ahead of earnings »

Hi Crush Partners calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

NFLX

Netflix

$152.16

8.33 (5.79%)

, FB

Facebook

$146.49

1.02 (0.70%)

13:32
04/26/17
04/26
13:32
04/26/17
13:32
Hot Stocks
FCC chairman Pai proposes to roll back net neutrality rules »

As previewed in recent…

NFLX

Netflix

$152.16

8.33 (5.79%)

FB

Facebook

$146.49

1.02 (0.70%)

AMZN

Amazon.com

$907.62

0.21 (0.02%)

GOOG

Alphabet

$872.30

9.54 (1.11%)

GOOGL

Alphabet Class A

$888.84

9.91 (1.13%)

CMCSA

Comcast

$38.49

0.48 (1.26%)

CMCSK

Comcast

T

AT&T

$40.11

0.17 (0.43%)

VZ

Verizon

$47.29

0.5937 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 23

    May

  • 05

    Jun

MPLX

MPLX

$36.39

-0.26 (-0.71%)

13:31
04/26/17
04/26
13:31
04/26/17
13:31
Hot Stocks
MPLX raises quarterly distribution 4% to 54c per unit »

MPLX LP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CREE

Cree

$24.82

0.07 (0.28%)

, IFNNY

Infineon

$20.70

0.12 (0.58%)

13:29
04/26/17
04/26
13:29
04/26/17
13:29
Recommendations
Cree, Infineon analyst commentary  »

Roth Capital says Cree…

CREE

Cree

$24.82

0.07 (0.28%)

IFNNY

Infineon

$20.70

0.12 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 09

    May

IART

Integra LifeSciences

$43.74

0.86 (2.01%)

13:27
04/26/17
04/26
13:27
04/26/17
13:27
Recommendations
Integra LifeSciences analyst commentary  »

Integra LifeSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

AA

Alcoa

$36.37

-0.12 (-0.33%)

, KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Periodicals
Commerce Secretary to announce plan to investigate aluminum imports, CNBC says »

Commerce Secretary Wilbur…

AA

Alcoa

$36.37

-0.12 (-0.33%)

KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

CENX

Century Aluminum

$13.62

0.99 (7.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

ZIOPHARM

$7.09

0.25 (3.66%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Options
Ziopharm call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 02

    Jun

  • 06

    Jun

13:20
04/26/17
04/26
13:20
04/26/17
13:20
General news
Treasury Action: yields jerked higher »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
04/26/17
04/26
13:17
04/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
04/26/17
04/26
13:16
04/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
5-Yr Note Auction Coupon Rate data reported »

5-Yr Note Auction Coupon…

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
Treasury's $34 B 5-year sale was poor, as feared »

Treasury's $34 B…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
5-Yr Note Auction Total Amount data reported »

5-Yr Note Auction Total…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Export Prices data reported. »

April Export Prices at % …

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Import Prices data reported. »

April Import Prices at % …

EEM

MSCI Emerging Markets Index

$40.04

-0.16 (-0.40%)

13:11
04/26/17
04/26
13:11
04/26/17
13:11
Options
Notable put spreads in the iShares Emerging Markets ETF »

Notable put spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$227.78

1.15 (0.51%)

, BAC

Bank of America

$24.08

0.095 (0.40%)

13:08
04/26/17
04/26
13:08
04/26/17
13:08
Periodicals
Fed looks to restructure big bank supervision panel, WSJ says »

The Fed is restructuring…

GS

Goldman Sachs

$227.78

1.15 (0.51%)

BAC

Bank of America

$24.08

0.095 (0.40%)

C

Citi

$60.43

0.2199 (0.37%)

WFC

Wells Fargo

$54.90

0.335 (0.61%)

JPM

JPMorgan

$88.61

0.345 (0.39%)

MS

Morgan Stanley

$44.65

0.38 (0.86%)

USB

U.S. Bancorp

$52.36

0.225 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 09

    May

  • 11

    May

  • 19

    May

  • 22

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

X

U.S. Steel

$23.27

-7.84 (-25.20%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Downgrade
U.S. Steel rating change  »

U.S. Steel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CCCR

China Commercial Credit

$1.82

0.4101 (29.09%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Syndicate
Breaking Syndicate news story on China Commercial Credit »

China Commercial Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.